Gastrointestinal stromal tumors

By A. Darnell, E. Dalmau, C. Pericay, E. Musulen, J. Martin, J. Puig, A. Malet, E. Saigí, M. Rey. Abdominal Imaging, 2006

975 citations recorded by the source corpus.

Subfields: Gastroenterology, Surgery

View Paper: https://www.semanticscholar.org/paper/d1a743f124ada8a1a9242d4b02b9608140a2a94d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. H. B. EL‐SERAG

Citations in the corpus

• The Epidemiology of Malignant Gastrointestinal Stromal Tumors: An Analysis of 1,458 Cases from 1992 to 2000 (2005, background): “However, another report in 2001 estimated the incidence to be as high as 10,000 new cases a year in the United States (11).”
• Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era (2005, neutral): “Clinical-incidental 60 (21) 24/36 74 (42–89) Gastric (23), duodenum (1), jejunum-ileum (32), colon (2), omentum (2) 2.”
• Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. (2016, methodology): “Although, KIT (CD117) immunohistochemistry is a reliable diagnostic tool in the diagnosis of GIST [15], the (few) cases of KITnegative GISTs, GISTs showing unusual morphology as well as GISTs which progress during or after treatment with imatinib/ sunitinib can be a challenge for pathologists and cl”